ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.57
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,190.74
0.47%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) News

Assembly Biosciences (ASMB)

Assembly Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ASMB
DateTimeSourceHeadlineSymbolCompany
28/03/202420:05GlobeNewswire Inc.Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
08/02/202413:00GlobeNewswire Inc.Assembly Biosciences Announces Effective Date of Reverse Stock SplitNASDAQ:ASMBAssembly Biosciences Inc
02/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
19/01/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
17/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
04/01/202413:00GlobeNewswire Inc.Assembly Biosciences Provides Anticipated Development Milestones for 2024NASDAQ:ASMBAssembly Biosciences Inc
21/12/202321:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ASMBAssembly Biosciences Inc
21/12/202321:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202321:10Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202321:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
07/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
22/11/202321:12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
22/11/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
10/11/202321:05GlobeNewswire Inc.Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ASMBAssembly Biosciences Inc
10/11/202313:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
08/11/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
08/11/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
08/11/202321:05GlobeNewswire Inc.Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
08/11/202313:00GlobeNewswire Inc.Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical OfficerNASDAQ:ASMBAssembly Biosciences Inc
03/11/202320:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
31/10/202320:19Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ASMBAssembly Biosciences Inc
31/10/202316:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
17/10/202313:44Dow Jones NewsAssembly Biosciences Shares Soar Premarket on Gilead PactNASDAQ:ASMBAssembly Biosciences Inc
17/10/202312:51Dow Jones NewsGilead Taking Stake in Assembly Bio Under Antiviral CollaborationNASDAQ:ASMBAssembly Biosciences Inc
17/10/202312:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
17/10/202312:00Business WireGilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral DiseasesNASDAQ:ASMBAssembly Biosciences Inc
11/10/202313:00GlobeNewswire Inc.Assembly Biosciences to Present New Data at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
04/10/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
04/10/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
04/10/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ASMB

Your Recent History

LSE
CHLL
Chill Brands
LSE
AGL
Angle
LSE
SRSP
Sirius Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
SCLP
Scancell
LSE
AAU
Ariana Resources
LSE
POS
Plexus
LSE
SBTX
Skinbiotherapeutics
LSE
SCE
Surface Transforms
LSE
INSG
Insig Ai
LSE
HUM
Hummingbird Resources
LSE
LLOY
Lloyds Banking
LSE
BIRD
Blackbird
LSE
APTA
Aptamer
LSE
ALBA
Alba Mineral Resources
LSE
BT.A
Bt
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved